Paper73643
Mitochondrial calcium overload: A general mechanism for cell-necrosis in muscle diseases.
Wrogemann K and 1 other. Lancet, 1976. Cited by 460 papers, by iCite.
Cite this record
ConductScience Library. Mitochondrial calcium overload: A general mechanism for cell-necrosis in muscle diseases. Papers, record 73643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/73643
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mitochondrial calcium overload: A general mechanism for cell-necrosis in muscle diseases.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calcium | Major topic |
| Mitochondria, Muscle | Major topic |
| Muscles | Major topic |
| Muscular Dystrophies | Major topic |
| Humans | |
| Models, Biological | |
| Necrosis | |
| Oxidative Phosphorylation |
Source PubMed
Cited by100
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 460 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42352253 | Targeting Oxidative Stress and Inflammation in Pembrolizumab-Induced Renal Injury: A Comparative Evaluation of the Protective Effects of Flunarizine and Carvacrol in Rats. | Biomolecules | 2026 | https://conductscience.org/library/papers/42352253 | PubMed |
| 41742249 | Role of mitochondrial dysfunction in muscle wasting in cancer cachexia: a narrative review. | J Transl Med | 2026 | https://conductscience.org/library/papers/41742249 | PubMed |
| 41113295 | Rhabdomyolysis Induced by Irbesartan-Hydrochlorothiazide in an Elderly Patient. | Clin Case Rep | 2025 | https://conductscience.org/library/papers/41113295 | PubMed |
| 40321007 | Perspectives on the interpretation of mitochondrial responses during skeletal muscle disuse-induced atrophy. | J Physiol | 2025 | https://conductscience.org/library/papers/40321007 | PubMed |
| 39321180 | Ultrastructural changes in cardiac and skeletal myoblasts following in vitro exposure to monensin, salinomycin, and lasalocid. | PLoS One | 2024 | https://conductscience.org/library/papers/39321180 | PubMed |
| 39056750 | Cardiomyopathy in Duchenne Muscular Dystrophy and the Potential for Mitochondrial Therapeutics to Improve Treatment Response. | Cells | 2024 | https://conductscience.org/library/papers/39056750 | PubMed |
| 38371826 | New Pathophysiological Insights from Serum Proteome Profiling in Equine Atypical Myopathy. | ACS Omega | 2024 | https://conductscience.org/library/papers/38371826 | PubMed |
| 37737731 | Calcium handling dysfunction and cardiac damage following acute ventricular preload challenge in the dystrophin-deficient mouse heart. | Am J Physiol Heart Circ Physiol | 2023 | https://conductscience.org/library/papers/37737731 | PubMed |
| 37460667 | Identity, structure, and function of the mitochondrial permeability transition pore: controversies, consensus, recent advances, and future directions. | Cell Death Differ | 2023 | https://conductscience.org/library/papers/37460667 | PubMed |
| 36265896 | Dlk1-Dio3 cluster miRNAs regulate mitochondrial functions in the dystrophic muscle in Duchenne muscular dystrophy. | Life Sci Alliance | 2023 | https://conductscience.org/library/papers/36265896 | PubMed |
| 35208266 | The Role of Taurine in Skeletal Muscle Functioning and Its Potential as a Supportive Treatment for Duchenne Muscular Dystrophy. | Metabolites | 2022 | https://conductscience.org/library/papers/35208266 | PubMed |
| 34579193 | Rhabdomyolysis Following Ad26.COV2.S COVID-19 Vaccination. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/34579193 | PubMed |
| 34533019 | A revised model for mitochondrial dysfunction in Duchenne muscular dystrophy. | Eur J Transl Myol | 2021 | https://conductscience.org/library/papers/34533019 | PubMed |
| 34298968 | Skeletal Muscle Mitochondria Dysfunction in Genetic Neuromuscular Disorders with Cardiac Phenotype. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34298968 | PubMed |
| 33995132 | Looking Back to the Future of Mitochondrial Research. | Front Physiol | 2021 | https://conductscience.org/library/papers/33995132 | PubMed |
| 33733717 | Translational research on Myology and Mobility Medicine: 2021 semi-virtual PDM3 from Thermae of Euganean Hills, May 26 - 29, 2021. | Eur J Transl Myol | 2021 | https://conductscience.org/library/papers/33733717 | PubMed |
| 33489533 | A Case of Methyl Ethyl Ketone Peroxide Ingestion Complicated by Rhabdomyolysis. | Cureus | 2020 | https://conductscience.org/library/papers/33489533 | PubMed |
| 32499563 | miR-379 links glucocorticoid treatment with mitochondrial response in Duchenne muscular dystrophy. | Sci Rep | 2020 | https://conductscience.org/library/papers/32499563 | PubMed |
| 31661602 | Tracking intra- and inter-organelle signaling of mitochondria. | FEBS J | 2019 | https://conductscience.org/library/papers/31661602 | PubMed |
| 31574188 | CRISPR/Cas9-Based Dystrophin Restoration Reveals a Novel Role for Dystrophin in Bioenergetics and Stress Resistance of Muscle Progenitors. | Stem Cells | 2019 | https://conductscience.org/library/papers/31574188 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/73643
GET https://conductscience.org/api/papers/v1/73643/cited_by?page=2